Inventor · disambiguated record
Joshua Courtney Horan
Also filed as: HORAN JOSHUA COURTNEY
11 granted patents·9 pending applications·32 citations·filing 2008–2025
86Inventor score
Files withNUVALENT INC12BOEHRINGER INGELHEIM INT4BARBOSA JR ANTONIO JOSE DEL MORAL1BENTZIEN JOERG MARTIN1BOSANAC TODD1
Top patents by PatentIndex Score
20 records- 0194US11542278B1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2021·Granted Jan 3, 2023·4 cites·30 claims
- 0293US11667649B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2021·Granted Jun 6, 2023·3 cites·31 claims
- 0390US8940893B2Heteroaromatic compounds as BTK inhibitorsBOSANAC TODD·Filed 2014·Granted Jan 27, 2015·19 cites·10 claims
- 0487US10875852B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 29, 2020·2 cites·12 claims
- 0586US12037346B2Amino-substituted heteroaryls for treating cancers with EGFR mutationsNUVALENT INC·Filed 2022·Granted Jul 16, 2024·1 cites·43 claims
- 0682US10138229B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·2 cites·20 claims
- 0778US2024352037A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2024·Application pending·0 cites
- 0874US12054498B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2022·Granted Aug 6, 2024·0 cites·48 claims
- 0973US12275742B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2022·Granted Apr 15, 2025·0 cites·31 claims
- 1072US2024327435A1Amino-substituted heterocycles for treating cancers with egfr mutationsNUVALENT INC·Filed 2024·Application pending·0 cites
- 1168US2025382304A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2025·Application pending·0 cites
- 1264US2024317771A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2024·Application pending·0 cites
- 1363US8552205B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amidesBARBOSA JR ANTONIO JOSE DEL MORAL·Filed 2008·Granted Oct 8, 2013·1 cites·49 claims
- 1463US2025326769A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2023·Application pending·0 cites
- 1562US12043626B2Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2022·Granted Jul 23, 2024·0 cites·36 claims
- 1660US2014045813A1Heteroaromatic compounds as btk inhibitorsBENTZIEN JOERG MARTIN·Filed 2013·Application pending·0 cites
- 1759US2017320867A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1854US2016031872A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1950US2023322797A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2023·Application pending·0 cites
- 2027US8575360B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amidesLEMIEUX RENE MARC·Filed 2010·Granted Nov 5, 2013·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Joshua Courtney Horan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →